J. Wagner

957 total citations
13 papers, 744 citations indexed

About

J. Wagner is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, J. Wagner has authored 13 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in J. Wagner's work include Renin-Angiotensin System Studies (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Receptor Mechanisms and Signaling (2 papers). J. Wagner is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Receptor Mechanisms and Signaling (2 papers). J. Wagner collaborates with scholars based in Switzerland, Germany and Netherlands. J. Wagner's co-authors include M. Paul, V J Dzau, Detlev Ganten, A.H. Jan Danser, JJ Mullins, Maarten A.D.H. Schalekamp, J. W. Faigle, F. H. M. Derkx, Miloslav Šulc and Karl Schmid and has published in prestigious journals such as Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and British Journal of Ophthalmology.

In The Last Decade

J. Wagner

12 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Wagner Switzerland	8	311	201	166	156	126	13	744
Romulus K. Brazzell United States	17	95 0.3×	297 1.5×	32 0.2×	78 0.5×	117 0.9×	37	773
Robert B. Wallis United Kingdom	18	233 0.7×	200 1.0×	54 0.3×	148 0.9×	10 0.1×	46	794
W J Jusko United States	14	32 0.1×	194 1.0×	92 0.6×	99 0.6×	29 0.2×	29	773
Himanshu V. Kothari United States	14	27 0.1×	250 1.2×	104 0.6×	162 1.0×	87 0.7×	23	745
J E Roulston United Kingdom	18	417 1.3×	314 1.6×	213 1.3×	81 0.5×	6 0.0×	47	967
K. Carr United States	11	117 0.4×	212 1.1×	108 0.7×	437 2.8×	7 0.1×	17	1.0k
Lin Liao China	20	81 0.3×	461 2.3×	373 2.2×	52 0.3×	48 0.4×	106	1.1k
G A FitzGerald United States	10	294 0.9×	180 0.9×	61 0.4×	329 2.1×	5 0.0×	14	888
Chantale Simard Canada	15	264 0.8×	216 1.1×	48 0.3×	78 0.5×	15 0.1×	42	623
Yoshimi Imura Japan	16	246 0.8×	338 1.7×	162 1.0×	117 0.8×	7 0.1×	31	1.0k

Countries citing papers authored by J. Wagner

Since Specialization

Citations

This map shows the geographic impact of J. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Wagner more than expected).

Fields of papers citing papers by J. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Wagner. The network helps show where J. Wagner may publish in the future.

Co-authorship network of co-authors of J. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of J. Wagner. A scholar is included among the top collaborators of J. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Wagner. J. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wagner, J., et al.. (2001). Synthesis of derivatives of the novel cyclophilin-binding immunosuppressant sanglifehrin A with reduced numbers of polar functions. Bioorganic & Medicinal Chemistry Letters. 11(12). 1609–1612. 7 indexed citations

Steckelings, U. Muscha, Serge P. Bottari, Monika Stoll, J. Wagner, & Thomas Unger. (1998). Repression of c- fos and c- jun gene expression is not part of AT 2 receptor coupled signal transduction. Journal of Molecular Medicine. 76(3-4). 202–207. 16 indexed citations

Pinto, Yigal M., Hendrik Buikema, Wiek H. van Gilst, et al.. (1997). Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats. Journal of Molecular Medicine. 75(5). 371–377. 43 indexed citations

Wagner, J., A.H. Jan Danser, F. H. M. Derkx, et al.. (1996). Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.. British Journal of Ophthalmology. 80(2). 159–163. 227 indexed citations

Paul, M., J. Wagner, & V J Dzau. (1993). Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.. Journal of Clinical Investigation. 91(5). 2058–2064. 206 indexed citations

Ciechanowicz, Andrzej, Michael Bäder, J. Wagner, & Detlev Ganten. (1993). Extrahepatic Transcription of Plasma Prekallikrein Gene in Human and Rat Tissues. Biochemical and Biophysical Research Communications. 197(3). 1370–1376. 13 indexed citations

Waldmeier, Felix, G. Kaiser, Roland Ackermann, et al.. (1991). The disposition of [¹⁴C]-labelled benazepril HC1 in normal adult volunteers after single and repeated oral dose. Xenobiotica. 21(2). 251–261. 26 indexed citations

Dieterle, W., J. W. Faigle, P Imhof, Miloslav Šulc, & J. Wagner. (1984). The metabolic fate of [¹⁴C]oxaprotiline · HCl in man. I. Disposition and preliminary pharmacokinetics. Xenobiotica. 14(4). 303–310. 6 indexed citations

Lode, H., et al.. (1980). Clinical Pharmacology of a New Ureidopenicillin: Bay K 4999. Chemotherapy. 26(2). 81–90. 2 indexed citations

10.

Rieß, W., H. Stierlin, P.H. Degen, et al.. (1978). Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent Voltaren. Scandinavian Journal of Rheumatology. 7(sup22). 17–29. 166 indexed citations

11.

Dieterle, W., J. Wagner, & J. W. Faigle. (1976). Binding of chlorthalidone (Hygroton�) to blood components in man. European Journal of Clinical Pharmacology. 10(1). 37–42. 28 indexed citations

12.

Spring, P, et al.. (1975). [Various aspects of the pharmacokinetics of Celospor with special reference to its affinity to cerebrospinal fluid].. PubMed. 27. 6–12. 3 indexed citations

13.

M�ller, D., J. Wagner, & Florian Strasser. (1972). The effect of phenylbutazone on the growth of murine fibroblasts in dependence of the degree of serum-protein binding. Naunyn-Schmiedeberg s Archives of Pharmacology. 273(3). 307–312. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact